Amanda (Ying) Wang is an accomplished pharmaceutical executive with extensive expertise in translational science, particularly in oncology. Currently serving as Vice President at Bayer Pharmaceuticals, Wang leads global oncology initiatives and oversees numerous programs within Radiopharmaceutical Therapy, Precision Molecular Oncology, and Immuno-Oncology. In previous roles, Wang successfully directed biomarker development and clinical strategies at both Bayer and Novartis, contributing to late-stage research and clinical programs in Immuno-Oncology. An academic background includes a Ph.D. in Biochemistry and Molecular Biology from the University of Virginia, an MA in Biostatistics from Boston University, and a BS in Biology from Fudan University. Wang has demonstrated a strong commitment to advancing precision medicine through leadership in biomarker strategies and multi-disciplinary collaboration.
This person is not in any teams
This person is not in any offices